name: | Isepamicin |
ATC code: | J01GB11 | route: | intravenous |
n-compartments | 2 |
Isepamicin is an aminoglycoside antibiotic, structurally related to gentamicin and amikacin, primarily used for the treatment of severe infections caused by Gram-negative bacteria. It was mainly developed and used in some Asian countries, but is not globally approved or widely available today.
Pharmacokinetic parameters in adult patients with normal renal function.
Barr, WH, et al., & Affrime, MB (1995). Pharmacokinetics of isepamicin. Journal of chemotherapy (Florence, Italy) 7 Suppl 2 53–61. PUBMED:https://pubmed.ncbi.nlm.nih.gov/8622111
Tod, M, et al., & Petitjean, O (1996). Population pharmacokinetic study of isepamicin with intensive care unit patients. Antimicrobial agents and chemotherapy 40(4) 983–987. DOI:10.1128/AAC.40.4.983 PUBMED:https://pubmed.ncbi.nlm.nih.gov/8849264
Yombi, JC, et al., & Vandercam, B (2005). Key pharmacokinetic parameters of isepamicin in febrile neutropenic cancer patients and in women with acute pelvic inflammatory disease. Journal of chemotherapy (Florence, Italy) 17(5) 521–526. DOI:10.1179/joc.2005.17.5.521 PUBMED:https://pubmed.ncbi.nlm.nih.gov/16323441